Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-23-000096 General Corporate
Debt relative to revenue 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
105.03% · OPTIONAL · VALID
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.26% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
50.49% · OPTIONAL · VALID
Revenue growth 33th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
7.88% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
5.30% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
68.93% · CORE · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
45.25% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
14.67% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.06% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 9/9 normalized Level 3 Jan 29, 2023 9/9 normalized Level 3 Apr 30, 2023 9/9 normalized Level 3 Jul 30, 2023 9/9 normalized Level 3 Oct 29, 2023 9/9 normalized Level 3 Feb 4, 2024 9/9 normalized Level 3 May 5, 2024 9/9 normalized Level 3 Aug 4, 2024 9/9 normalized Level 3 Nov 3, 2024 9/9 normalized Level 3 Feb 2, 2025 9/9 normalized Level 3 May 4, 2025 9/9 normalized Level 3 Aug 3, 2025 9/9 normalized Level 3 Nov 2, 2025 9/9 normalized Level 3 Feb 1, 2026 9/9 normalized Level 3 May 3, 2026 9/9 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 430.62%
Current 105.03%
Delta -325.59% Capex Intensity Decreased
Previous 1.37%
Current 1.26%
Delta -0.11% Cash Generation Decreased
Previous 53.17%
Current 50.49%
Delta -2.68% Growth Increased
Previous 4.87%
Current 7.88%
Delta 3.01% Inventory Pressure Decreased
Previous 20.75%
Current 5.30%
Delta -15.45% Margin Decreased
Previous 69.45%
Current 68.93%
Delta -0.52% Profitability Increased
Previous 43.44%
Current 45.25%
Delta 1.80% R And D Intensity Decreased
Previous 15.30%
Current 14.67%
Delta -0.63% Sbc Intensity Decreased
Previous 7.09%
Current 6.06%
Delta -1.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.